Phase IV randomised double masked clinical trial: Assessing morning versus evening dosing of a fixed dose combination of Travoprost 0.004% / Timolol Maleate 0.5% in patients with primary open angle glaucoma or ocular hypertension.
Read time: 1 mins
Last updated:11th Jan 2008
To assess the IOP-lowering efficacy at 9 am, 11 am and 4 pm of a fixed combination of Travoprost 0.004% / Timolol Maleate 0.5% dosed in the morning versus the same fixed combination dosed in the evening, in patients with open-angle glaucoma or ocular hypertension, who have an IOP insufficiently controlled (IOP ? 19 to ? 28 mmHg) by prior prostaglandin analogue monotherapy.
|Study start date||2008-01-11|